key: cord-0855379-yrid3499 authors: Xiao, Fang; Wan, Peiqi; Wei, Qiuling; Wei, Guiyang; Yu, Yanhong title: Prolonged fecal shedding of SARS‐CoV‐2 in a young immunocompetent COVID‐19 patient: A case report and literature overview date: 2022-03-22 journal: J Med Virol DOI: 10.1002/jmv.27694 sha: 5938428ea20044be30e94691bff243f9f7360411 doc_id: 855379 cord_uid: yrid3499 Clinicians are facing several challenges in tackling coronavirus disease 2019 (COVID‐19); one issue is prolonged detection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) RNA. Here, we describe a case of SARS‐CoV‐2 infection in a young immunocompetent patient with a virological course lasting for 71 days. Following antiviral treatment, but no additional glucocorticoid or interferon therapy, the patient recovered from COVID‐19 pneumonia (moderate). Detection of viral RNA via throat swabs showed negative results. However, the viral RNA reappeared and persisted in stool samples for an additional 27 days, while the patient remained asymptomatic and exhibited no abnormal signs. This case indicates that SARS‐CoV‐2 can result in a prolonged fecal RNA shedding, even in an immunocompetent patient with zero exposure to immunosuppressive therapies. The coronavirus disease 2019 (COVID-19) pandemic is a global public health crisis that has caused social and economic disasters in many countries. Managing the source of infection is crucial for controlling this epidemic; however, the emergence of asymptomatic carriers, patients experiencing relapse, and prolonged viral shedding in patients, frequently overlooked by infection prevention and control protocols, hinder the control of the source of infection. [1] [2] [3] Therefore, understanding the clinical course and virological course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is important. In China, two consecutive negative results of nucleic acid tests for SARS-CoV-2 from respiratory samples are required to end the quarantine of COVID-19 patients. 4 However, clinicians face a predicament in the case of patients with long-term viral shedding through the respiratory tract or feces. Evidence indicates that SARS-CoV-2 RNA positivity may persist for several weeks following symptom resolution [5] [6] [7] ; fecal samples have shown positive results for a mean of 27.9 days after the onset of symptoms. The fecal positive timeline is longer than that for respiratory samples, 8 with fecal viral shedding persisting for 1-33 days following a negative nasopharyngeal swab test result. 7 In cases of exceptionally prolonged fecal shedding (shedding for >70 days), patient age, glucocorticoid use, and immunocompromised status were identified as the major factors for delayed SARS-CoV-2 RNA clearance. [9] [10] [11] Here, we report the case of a young immunocompetent COVID-19 patient who achieved clinical recovery but exhibited persistently positive results upon a fecal SARS-CoV-2 nucleic acid test for up to 71 days after disease onset. We studied the combined long-term treatment and management practices used for this patient to analyze the clinical characteristics, pathogenesis, response to antiviral treatment, and infectivity. Table 1 , persistent SARS-CoV-2 RNA shedding has been documented 6,13-16 ; however, the prolonged persistence of detectible SARS-CoV-2 is generally identified in upper respiratory tract specimens, not fecal samples. The longest reported case of fecal viral shedding was 100 days and was found in an 11-month-old baby. Multi-sample studies have revealed several independent parameters associated with extended SARS-CoV-2 RNA shedding, including corticosteroid treatment, male sex, older age, delayed hospital admission, immunoglobulin use, lymphocyte count, invasive mechanical ventilation, lack of lopinavir/ritonavir treatment, and maximum body temperature over 38.5°C. [17] [18] [19] [20] [21] [22] [23] [24] Furthermore, a decrease in the humoral immune response, to some extent, was considered to be the root cause of prolonged viral shedding. 25 Interestingly, the patient in our study was particularly young, had no fever at admission, showed no abnormalities upon routine blood tests, and received no immunosuppressive medicines during the hospital stay. He was healthy and had no underlying conditions. Currently, the Virological assessment of hospitalized patients with COVID-2019 COVID-19 transmission through asymptomatic carriers is a challenge to containment. Influenza Other Respir Viruses Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? Diagnosis and treatment of 2019-nCoV pneumonia in China (version 8, in Chinese). China National Health Commission Incidence and persistence of viral shedding in COVID-19 post-acute patients with negativized pharyngeal swab: a systematic review Persistent SARS-COV-2 RNA positivity in a patient for 92 days after disease onset: a case report Persistent viral shedding of SARS-CoV-2 in faeces-a rapid review Prolonged presence of SARS-CoV-2 viral RNA in faecal samples Glucocorticoid therapy delays the clearance of SARS-CoV-2 RNA in an asymptomatic COVID-19 patient Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review Prolonged SARS-CoV-2 RNA detection in anal/rectal swabs and stool specimens in COVID-19 patients after negative conversion in nasopharyngeal RT-PCR test Persistent detection of SARS-CoV-2 RNA in patients and healthcare workers with COVID-19 Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer An unusual COVID-19 case with over four months of viral shedding in the presence of low neutralizing antibodies: a case report An Asymptomatic SARS-CoV-2-infected infant with persistent fecal viral RNA shedding in a family cluster: a rare case report Long-term positivity to SARS-CoV-2: a clinical case of COVID-19 with persistent evidence of infection Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19 Fecal viral shedding in COVID-19 patients: clinical significance, viral load dynamics and survival analysis Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes Factors Associated with prolonged viral RNA Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19 Factors associated with the duration of viral shedding in adults with COVID-19 outside of Wuhan, China: a retrospective cohort study Clinical characteristics and factors associated with long-term viral excretion in patients with severe acute respiratory syndrome coronavirus 2 infection: a single-center 28-day study Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report SARS-CoV-2: targeted managements and vaccine development A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Virological assessment of SARS-CoV-2 The kinetics of viral load and antibodies to SARS-CoV-2 Detection of SARS-CoV-2 in different types of clinical specimens Detection and isolation of SARS-CoV-2 in serum, urine, and stool specimens of COVID-19 patients from the Republic of Korea The authors declare no conflicts of interest. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. http://orcid.org/0000-0002-7153-454XPeiqi Wan http://orcid.org/0000-0001-8365-7531Qiuling Wei http://orcid.org/0000-0002-4672-1706Guiyang Wei http://orcid.org/0000-0001-5560-706X